ARBUTUS BIOPHARMA CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.73 USD | +0.37% |
|
+0.37% | +9.20% |
| Apr. 05 | Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit | MT |
| Apr. 04 | Moderna Suffers Setback in Lawsuit by Arbutus | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | |
|---|---|---|---|---|
| Last | 2.75 $ | 2.75 $ | 2.72 $ | 2.73 $ |
| Volume | 1 089 465 | 348 057 | 323 341 | 406 742 |
| Change | +4.17% | 0.00% | -1.09% | +0.37% |
| Opening | 2.64 | 2.75 | 2.74 | 2.73 |
| High | 2.75 | 2.78 | 2.75 | 2.78 |
| Low | 2.64 | 2.74 | 2.68 | 2.70 |
Performance
| 1 day | +0.37% | ||
| 1 week | +0.37% | ||
| Current month | +5.81% | ||
| 1 month | +5.00% | ||
| 3 months | +14.71% | ||
| 6 months | +57.80% | ||
| Current year | +9.20% | ||
| 1 year | +8.76% | ||
| 3 years | -21.10% | ||
| 5 years | +0.37% | ||
| 10 years | -80.35% |
Volumes
marketsDaily volume
406 742
Estimated daily volume
406 742
Avg. Volume 20 sessions
1 345 188
Daily volume ratio
0.30
Avg. Volume 20 sessions USD
3 672 363.24
Record volume 1
322 127 000
Record volume 2
219 523 600
Record volume 3
109 113 500
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
491 877 558
Net sales (CAD)
24 628 950
Net sales (USD)
18 003 762
Number of employees
73
Sales / Employee (CAD)
337 383
Sales / Employee (USD)
246 627
Free-Float
76.66 %
Free-Float capitalization (USD)
377 052 994
Average Daily Capital Traded
0.55%
Highs and lows
1 week
2.64
2.78
1 month
2.303.29
Current year
2.213.29
1 year
1.693.29
3 years
1.696.50
5 years
0.829.02
10 years
0.8229.93
Indicators
Moving average 5 days
2.72
Moving average 20 days
2.83
Moving average 50 days
2.77
Moving average 100 days
2.57
Price spread / (MMA5)
-0.51%
Price spread / (MMA20)
+3.82%
Price spread / (MMA50)
+1.41%
Price spread / (MMA100)
-5.88%
STIM
RSI 9 days
43.45
RSI 14 days
46.65
Sector Comparison - Biopharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.37% | +0.37% | +9.20% | +8.76% | 492M | ||
| -1.85% | +1.41% | -4.66% | -10.10% | 86.13B | ||
| -1.28% | -1.41% | +1.32% | -1.03% | 39.82B | ||
| +3.18% | +7.47% | -19.27% | -28.88% | 30.42B | ||
| +0.65% | +2.76% | +57.86% | +45.60% | 25.23B | ||
| -1.53% | -8.71% | -16.09% | -12.48% | 15.36B | ||
| +7.67% | +2.31% | -9.14% | -8.99% | 11.95B | ||
| +0.98% | -1.28% | -17.69% | -29.83% | 11.6B | ||
| +1.81% | -13.98% | -43.00% | -36.22% | 11.51B | ||
| +0.07% | +7.66% | +5.24% | +11.07% | 8.71B | ||
| +1.56% | +17.92% | -8.42% | +0.64% | 8.12B | ||
| +1.57% | +1.23% | +2.29% | +18.41% | 7.72B | ||
| 0.00% | +3.15% | +76.35% | +292.10% | 6.69B | ||
| -0.96% | +2.57% | -10.12% | +14.67% | 6.59B | ||
| -0.80% | -0.49% | -7.72% | +5.66% | 6.49B | ||
| +4.03% | +4.90% | -16.71% | -39.77% | 6.05B | ||
| Average | +0.97% | +1.49% | -0.04% | +14.35% | ||
| Weighted average by Cap. | +0.15% | +0.96% | -0.85% | +1.39% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
0fdedd906c58.y_AmTOosbAK1dNGkLg0vAfuT1KpOQXfvet_DHlL5Isk.pb1jCpNbPUWNRr7VGnxpcbLnnMN-KhCnIuuhdzyPc7m7vxAvp3wJev4_pg
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 2.73 | 57,999 | 361,262 |
| 03:59:58 pm | 2.72 | 100 | 303,263 |
| 03:59:55 pm | 2.72 | 100 | 303,163 |
| 03:59:55 pm | 2.72 | 149 | 303,063 |
| 03:59:55 pm | 2.72 | 262 | 302,914 |
| 03:59:53 pm | 2.72 | 146 | 302,652 |
| 03:59:53 pm | 2.72 | 146 | 302,506 |
| 03:59:53 pm | 2.72 | 200 | 302,360 |
| 03:59:53 pm | 2.72 | 200 | 302,160 |
| 03:59:53 pm | 2.72 | 236 | 301,960 |
Monthly variations
Annual change
| 2024 | +9.20% | ||
| 2023 | +7.30% | ||
| 2022 | -40.10% | ||
| 2021 | +9.58% | ||
| 2020 | +27.70% | ||
| 2019 | -27.42% | ||
| 2018 | -24.16% | ||
| 2017 | +106.12% | ||
| 2016 | -44.94% | ||
| 2015 | -70.63% | ||
| 2014 | +90.09% | ||
| 2013 | +60.69% | ||
| 2012 | +230.67% | ||
| 2011 | -68.09% | ||
| 2010 | -33.24% |
- Stock Market
- Equities
- ABUS Stock
- Quotes Arbutus Biopharma Corporation
